Susan Mahony is on the board of Zymeworks, Inc. and 9 other companies. She previously was Principal at Amgen, Inc., Principal at Bristol Myers Squibb Co., Senior Vice President of Eli Lilly & Co. President & General Manager at Eli Lilly Canada, Inc. and President & Senior Vice President at Lilly Oncology (both are subsidiaries of Eli Lilly & Co.) and Principal at Schering-Plough Corp.
Dr. Mahony received an MBA from London Business School and an undergraduate degree and a doctorate from the University of Aston.
|04/29/2022||1,658||Derivative/Non-derivative trans. at $98.56 per share.||163,413|
|04/29/2022||4,223||Derivative/Non-derivative trans. at $0 per share.||0|
|04/30/2021||4,357||Derivative/Non-derivative trans. at $94.62 per share.||412,260|
|04/30/2021||11,098||Derivative/Non-derivative trans. at $0 per share.||0|
|05/02/2020||4,725||Derivative/Non-derivative trans. at $35.62 per share.||168,305|
|05/02/2020||12,036||Derivative/Non-derivative trans. at $0 per share.||0|